Artificial Intelligence Algorithm-Based MRI in the Diagnosis of Complications after Renal Transplantation
- PMID: 36072641
- PMCID: PMC9398844
- DOI: 10.1155/2022/8930584
Artificial Intelligence Algorithm-Based MRI in the Diagnosis of Complications after Renal Transplantation
Abstract
This study was to explore the diagnostic value of magnetic resonance imaging (MRI) optimized by residual segmentation attention dual channel network (DRSA-U-Net) in the diagnosis of complications after renal transplantation and to provide a more effective examination method for clinic. 89 patients with renal transplantation were selected retrospectively, and all underwent MRI. The patients were divided into control group (conventional MRI image diagnosis) and observation group (MRI image diagnosis based on DRSA-U-Net). The accuracy of MRI images in the two groups was evaluated according to the comprehensive diagnostic results. The root mean square error (RMSE) and peak signal-to-noise ratio (PSNR) of DRSA-U-Net on T1WI and T2WI sequences were better than those of U-Net and dense U-Net (P < 0.05); comprehensive examination showed that 39 patients had obstruction between ureter and bladder anastomosis, 13 cases had rejection, 10 cases had perirenal hematoma, 5 cases had renal infarction, and 22 cases had no complications; the diagnostic sensitivity, specificity, accuracy, and consistency of the observation group were higher than those of the control group (P < 0.05). In the control group, the sensitivity, specificity, and accuracy in the diagnosis of complications after renal transplantation were 66.5%, 84.1%, and 78.32%, respectively; in the observation group, the sensitivity, specificity, and accuracy in the diagnosis were 67.8%, 86.7%, and 80.6%, respectively. DRSA-U-Net denoising algorithm can clearly display the information of MRI images on the kidney, ureter, and surrounding tissues, improve its diagnostic accuracy in complications after renal transplantation, and has good clinical application value.
Copyright © 2022 Hang Liu et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures






Similar articles
-
[The Application Value of Artificial Intelligence-based Filtering and Interpolated Image Reconstruction Algorithm in Abdominal Magnetic Resonance Image Denoising].Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Mar;52(2):293-299. doi: 10.12182/20210360104. Sichuan Da Xue Xue Bao Yi Xue Ban. 2021. PMID: 33829705 Free PMC article. Chinese.
-
Multimodal Magnetic Resonance Imaging to Diagnose Knee Osteoarthritis under Artificial Intelligence.Comput Intell Neurosci. 2022 Jun 23;2022:6488889. doi: 10.1155/2022/6488889. eCollection 2022. Comput Intell Neurosci. 2022. PMID: 35785062 Free PMC article.
-
Artificial Intelligence Algorithm-Based Lumbar and Spinal MRI for Evaluation of Efficacy of Chinkuei Shin Chewan Decoction on Lumbar Spinal Stenosis.Contrast Media Mol Imaging. 2021 Dec 29;2021:2700452. doi: 10.1155/2021/2700452. eCollection 2021. Contrast Media Mol Imaging. 2021. PMID: 35035312 Free PMC article. Clinical Trial.
-
Artificial Intelligence Algorithm-Based Computed Tomography Image of Both Kidneys in Diagnosis of Renal Dysplasia.Comput Math Methods Med. 2022 Jan 27;2022:5823720. doi: 10.1155/2022/5823720. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Dec 6;2023:9834943. doi: 10.1155/2023/9834943. PMID: 35126629 Free PMC article. Retracted. Clinical Trial.
-
Magnetic Resonance Imaging Features on Deep Learning Algorithm for the Diagnosis of Nasopharyngeal Carcinoma.Contrast Media Mol Imaging. 2022 May 25;2022:3790269. doi: 10.1155/2022/3790269. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 35677026 Free PMC article.
Cited by
-
Comprehensive analysis of necroptosis-related genes in renal ischemia-reperfusion injury.Front Immunol. 2023 Oct 27;14:1279603. doi: 10.3389/fimmu.2023.1279603. eCollection 2023. Front Immunol. 2023. PMID: 37965311 Free PMC article.
-
Artificial intelligence in kidney transplantation: a 30-year bibliometric analysis of research trends, innovations, and future directions.Ren Fail. 2025 Dec;47(1):2458754. doi: 10.1080/0886022X.2025.2458754. Epub 2025 Feb 5. Ren Fail. 2025. PMID: 39910843 Free PMC article. Review.
References
-
- Ferreri A. J. M., Cwynarski K., Pulczynski E., et al. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. The Lancet Haematology . 2016;3(5):217–227. doi: 10.1016/S2352-3026(16)00036-3. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical